U-Blot® Research Grade EcromeximabCat. No. WA2716$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade EcromeximabCat. No. WA2716
U-Blot® Research Grade eclutatugCat. No. WA2715
U-Blot® Research Grade EcleralimabCat. No. WA2714
U-Blot® Research Grade EbronucimabCat. No. WA2713
U-Blot® Research Grade Ebribafusp AlfaCat. No. WA2712
U-Blot® Research Grade EbrasodebartCat. No. WA2711
U-Blot® Research Grade EblasakimabCat. No. WA2710
U-Blot® Research Grade EbdarokimabCat. No. WA2709
U-Blot® Research Grade DXP-604Cat. No. WA2708
U-Blot® Research Grade DuvortuxizumabCat. No. WA2707
U-Blot® Research Grade DuvakitugCat. No. WA2706
U-Blot® Research Grade DusigitumabCat. No. WA2705